Drug Database · Clinicians

Inactivated poliomyelitis vaccine types 1 2

Brands (2) Poliovac, Imovax PolioShow all

Vaccine PH FDA category

Rx · Prescription drug3 PH productsPNF-listed
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Suspension for injection: 0.5 mL

Registered products in the Philippines

3 products registered with the Food and Drug Administration (FDA) Philippines list Inactivated poliomyelitis vaccine types 1 2 as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Also registered under: Inactivated Poliomyelitis Vaccine (Type 1,2 And 3) (1 product). Products registered under these spellings are included in the table and marked.

Verify on PH FDA portal

All registered products3
Philippine FDA-registered products for Inactivated poliomyelitis vaccine types 1 2
Package insert
Imovax PolioInactivated Poliomyelitis Vaccine (Type 1,2 And 3)Variant spelling
Formulation: One dose (0.5 mL) contains: Poliovirus type 1, Mahoney strain (inactivated)-40 D-antigen Units Poliovirus type 2, MFF-I strain (inactivated)- 8 D-antigen Units Poliovirus type 3, Saukett strain (inactivated) - 32 D-antigen Units Suspension For Injection (IM/SC)Pre-filled syringe x 0.5 mL (with needle) (Box of 1's)
Rx
Sanofi PasteurFrance
Importer: Sanofi Pasteur, Inc.
BR-498
May 21, 2027
PoliovacInactivated Poliomyelitis Vaccine (Types 1, 2 And 3)
0.5 mL Suspension For Injection (IM/SC)Type I Clear Vial x 0.5 mL (Box of 1's, 10's and 50's)
Rx
Serum Institute of India Private LimitedIndia
Faberco Life Sciences Inc.
BR-1290
Feb 9, 2028
PoliovacInactivated Poliomyelitis Vaccine (Types 1, 2 And 3)
Formulation: Each dose (0.5 mL) contains: Poliovirus type 1, Mahoney strain (inactivated)-40 D antigen units Poliovirus type 2, MEF-1 strain (inactivated)-8 D antigen units Poliovirus type 3, Saukett strain (inactivated)-32 D antigen units Suspension For Injection (Im/Sc)Multidose vial. 2.5 mL in 3 mL USP Type I glass vial with chlorobutyl rubber stopper, pink aluminium flip-off seal, and Vaccine Vial Monitor (Box of 50's) ine Vial
Rx
Serum Institute of India Private LimitedIndia
Faberco Life Sciences Inc.
BR-1379
Jul 13, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Formulary and coverage

Philippine National FormularyListed as Inactivated Poliomyelitis Vaccine (Types 1, 2 and 3)
PNF listingInj: 0.5 mL per dose, suspension for injection single- dose/multidose vial (IM, SC)
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  2. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .